MedPath

Yonsei University

Yonsei University logo
🇰🇷South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

A Qualitative Study on the Pain and Quality of Life of Patients With Fabry Disease

Recruiting
Conditions
Fabry Disease
First Posted Date
2023-01-10
Last Posted Date
2023-01-20
Lead Sponsor
Yonsei University
Target Recruit Count
10
Registration Number
NCT05679076
Locations
🇰🇷

Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

Safety and Efficacy of the Ultimaster Stent

Active, not recruiting
Conditions
Drug-eluting Stents
Coronary Artery Disease
Interventions
Device: ultimaster
First Posted Date
2023-01-10
Last Posted Date
2024-03-15
Lead Sponsor
Yonsei University
Target Recruit Count
204
Registration Number
NCT05677711
Locations
🇰🇷

Yongin Severance Hospital, Yongin, Gyeonggi-do, Korea, Republic of

Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma

Phase 2
Recruiting
Conditions
Primary Peritoneal Cancer
Mucinous Ovarian Cancer
Fallopian Tube Cancer
Interventions
First Posted Date
2022-12-27
Last Posted Date
2022-12-29
Lead Sponsor
Yonsei University
Target Recruit Count
37
Registration Number
NCT05665023
Locations
🇰🇷

Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI

Phase 4
Completed
Conditions
Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia
Interventions
First Posted Date
2022-12-22
Last Posted Date
2025-03-13
Lead Sponsor
Yonsei University
Target Recruit Count
108
Registration Number
NCT05661552
Locations
🇰🇷

Yongcheol Kim, Yongin, Gyeonggi-do, Korea, Republic of

CREATE Trial, Prospective, Observational Study

Recruiting
Conditions
Coronary Artery Disease
Drug Eluting Stent
First Posted Date
2022-12-20
Last Posted Date
2024-03-15
Lead Sponsor
Yonsei University
Target Recruit Count
300
Registration Number
NCT05658250
Locations
🇰🇷

Yongin Severance Hospital, Yongin, Gyeonggi-do, Korea, Republic of

Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR)

Active, not recruiting
Conditions
In-stent Restenosis
Interventions
Device: Genoss® DCB
First Posted Date
2022-12-19
Last Posted Date
2025-05-14
Lead Sponsor
Yonsei University
Target Recruit Count
260
Registration Number
NCT05656118
Locations
🇰🇷

Inje University Ilsan Paik Hospital, Goyang, Gyeonggi-do, Korea, Republic of

🇰🇷

Yongin Severance Hospital, Yonsei University, Yongin-si, Gyeonggi-do, Korea, Republic of

🇰🇷

Kyungpook National University College Hospital, Daegu, Gyeongsangnam-do, Korea, Republic of

and more 1 locations

Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors

Recruiting
Conditions
Ovarian Cancer
First Posted Date
2022-12-07
Last Posted Date
2022-12-07
Lead Sponsor
Yonsei University
Target Recruit Count
54
Registration Number
NCT05640024
Locations
🇰🇷

Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

Relative Importance of Cardiovascular Risk Factors and Echocardiographic Parameters Affecting Left Atrial Strain

Recruiting
Conditions
Heart Failure, Preserved Ejection Fraction
Heart Failure, Diastolic
Interventions
Diagnostic Test: Left atrial reservoir strain
First Posted Date
2022-12-06
Last Posted Date
2022-12-06
Lead Sponsor
Yonsei University
Target Recruit Count
2500
Registration Number
NCT05638230
Locations
🇰🇷

Minkwan Kim, Yongin, Gyeonggi, Korea, Republic of

Efficacy and Safety of Percutaneous Liver Biopsy With Needle Tract Plugging on Outpatient Basis

Not Applicable
Recruiting
Conditions
Image-guided Biopsy
Liver Biopsy
Interventions
Procedure: Coaxial method with needle-track plugging
Procedure: Conventional method
First Posted Date
2022-11-14
Last Posted Date
2022-11-14
Lead Sponsor
Yonsei University
Target Recruit Count
122
Registration Number
NCT05614973
Locations
🇰🇷

Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

Effect of Nociception Level Monitoring During Remimazolam-based Total Intravenous Anesthesia on Intraoperative Opioid Requirements and Postoperative Pain

Not Applicable
Recruiting
Conditions
Adult Patients Aged 19-64, Scheduled for Elective Arthroscopic Knee Surgery
Interventions
Device: Analgesia Nociception Index monitor
Device: Standard monitoring
First Posted Date
2022-11-14
Last Posted Date
2022-11-14
Lead Sponsor
Yonsei University
Target Recruit Count
58
Registration Number
NCT05615441
Locations
🇰🇷

Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath